News

Markets are bouncing back faster than ever. For some long-term investors, that could mark a compelling case for systematic investing during downturns.
Immunitybio Inc (($IBRX)) announced an update on their ongoing clinical study. ImmunityBio Inc. is conducting a study titled ‘Single Arm Study to ...
The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print ...
The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...
A sweeping new study has uncovered a powerful connection between long COVID and the challenges people face in everyday life.
Nick Millican's success in market timing isn't about supernatural insight—it's about building a systematic approach to uncertainty.
New York City-based Mount Sinai Health System has released the country’s first clinical manual for treating infection-associated chronic illnesses, according to an Aug. 13 news release. The clinical ...
New stem cell therapy has shown effective in boosting immune recovery for cats with feline infectious peritonitis.
The risk factors associated with insomnia onset were moderate to severe symptoms during acute COVID-19 illness (e.g., sleep ...
FM Global moved to dismiss, arguing Indorama could not sue directly and that the claim fell under a reinsurance agreement requiring litigation in Rhode Island. The court denied the motion, finding ...
Although softer US consumer sentiment presents a near-term headwind, we think Airbnb's global online travel agency position will strengthen over the next decade, driven by a leading alternative ...